activity
20242026
collaborators
Showing stat.MEShow all

10 papers · 1 filter

stat.ME2026

Shape-Preserving Covariate Adjustment via Empirical Likelihood in Randomized Experiment

Zhilan Lou, Jun Shao, Yuhan Qian +4

Covariate adjustment improves estimation efficiency in randomized experiments, but standard calibration and augmentation methods, when applied to distribution or survival functions…

stat.ME2026

Robust and Data-Adaptive Integration of Nonconcurrent Data in Platform Trials via Gaussian Processes

Yuhan Qian, Yu Du, Jingning Zhang +3

A platform trial is an innovative clinical trial design that enables simultaneous and continuous evaluation of multiple treatments within a single master protocol. Existing robust…

stat.ME2026

Evolving Longitudinal Patient Histories and Re-enrollment in Master Protocol Trials

Shiyu Wan, Yuhan Qian, Yanyao Yi +3

A master protocol trial uses a single overarching protocol to test multiple therapies, often across several diseases or subtypes. Although such trials offer considerable flexibilit…

stat.ME2026

Proximal Learning for Trials With External Controls: A Case Study in HIV Prevention

Yilin Song, Yinxiang Wu, Raphael J. Landovitz +9

With the advent of effective pre-exposure prophylaxis agents, active-controlled HIV prevention trials have become a common study design. Nevertheless, estimating absolute efficacy…

stat.ME2026

Covariate Adjustment for Wilcoxon Two Sample Statistic and Test

Zhilan Lou, Jun Shao, Ting Ye +3

We apply covariate adjustment to the Wincoxon two sample statistic and Wincoxon-Mann-Whitney test in comparing two treatments. The covariate adjustment through calibration not only…

stat.ME2026

The RobinCar Family: R Tools for Robust Covariate Adjustment in Randomized Clinical Trials

Marlena Bannick, Yuanyuan Bian, Gregory Chen +6

Purpose: Covariate adjustment is a powerful statistical technique that can increase efficiency in clinical trials. Recent guidance from the U.S. FDA provided recommendations and be…

stat.ME2025

Estimating treatment effects with competing intercurrent events in randomized controlled trials

Sizhu Lu, Yanyao Yi, Yongming Qu +3

The analysis of randomized controlled trials is often complicated by intercurrent events (IEs) -- events that occur after treatment initiation and affect either the interpretation…

stat.ME2024

From Estimands to Robust Inference of Treatment Effects in Master Protocol Trials

Yuhan Qian, Yifan Yi, Jun Shao +5

Master protocol trials use a single overarching protocol to evaluate multiple interventions, diseases, or disease subtypes, where individuals are often randomized to different subs…

stat.ME2024

Improve the Precision of Area Under the Curve Estimation for Recurrent Events Through Covariate Adjustment

Jiren Sun, Tuo Wang, Yanyao Yi +3

The area under the curve (AUC) of the mean cumulative function (MCF) has recently been introduced as a novel estimand for evaluating treatment effects in recurrent event settings,…

stat.ME2024

Clarifying the Role of the Mantel-Haenszel Risk Difference Estimator in Randomized Clinical Trials

Xiaoyu Qiu, Yuhan Qian, Jaehwan Yi +4

The Mantel-Haenszel (MH) risk difference estimator, commonly used in randomized clinical trials for binary outcomes, calculates a weighted average of stratum-specific risk differen…